Particulate contamination of lyophilized amphotericin B preparation during reconstitution process

被引:9
作者
Sendo, T [1 ]
Hirakawa, M [1 ]
Makino, K [1 ]
Nakashima, K [1 ]
Kataoka, Y [1 ]
Oishi, R [1 ]
机构
[1] Kyushu Univ, Fac Med, Dept Hosp Pharm, Higashi Ku, Fukuoka 8128582, Japan
关键词
amphotericin B; particulate contamination; silicone; X-ray analysis;
D O I
10.1046/j.1365-2710.2001.00328.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To investigate the effect of the reconstitution methods for the commercial amphotericin B preparation with respect to particulate contamination. Methods: The particle counts in amphotericin B solutions reconstituted according to three different methods and amphotericin B fluids made with intravenous fluids after reconstitution were performed using a light extinction method. The particle contaminants were identified with X-ray emission spectrometry attached to a scanning electron microscope. Results: Amphotericin B in a vial induced particle contamination during the reconstitution process, and the contamination was especially marked by shaking vigorously after injecting water into the vial. From the X-ray analysis, it appeared that the increased number of particles was derived from the amphotericin B-deoxycholate complex containing substances such as silicone released from the vial components. Amphotericin B fluid made with intravenous fluids after reconstitution also contained particles over the acceptable limits according to the Japanese or US pharmacopoeia. Conclusion: These findings suggest that reconstituted solutions should be filtered with membrane filters and diluted fluids with in-line filters.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 15 条
[1]   FILTRATION AND INFUSION PHLEBITIS - DOUBLE-BLIND PROSPECTIVE CLINICAL-STUDY [J].
DELUCA, PP ;
RAPP, RP ;
BIVINS, B ;
MCKEAN, HE ;
GRIFFEN, WO .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1975, 32 (10) :1001-1007
[2]   DOUBLE-BLIND EVALUATION OF 5-MUM FINAL FILTRATION TO REDUCE POST-INFUSION PHLEBITIS [J].
EVANS, WE ;
BARKER, LF ;
SIMONE, JV .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1976, 33 (11) :1160-1163
[3]   Evaluation of the in-line filters for the intravenous infusion of amphotericin B fluid [J].
Hirakawa, M ;
Makino, K ;
Nakashima, K ;
Kataoka, Y ;
Oishi, R .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1999, 24 (05) :387-392
[4]   IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID [J].
JOLY, V ;
FARINOTTI, R ;
SAINTJULIEN, L ;
CHERON, M ;
CARBON, C ;
YENI, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :177-183
[5]   STABILITY OF AMPHOTERICIN-B IN 5-PERCENT DEXTROSE INJECTION AT CONCENTRATIONS USED FOR ADMINISTRATION THROUGH A CENTRAL VENOUS LINE [J].
KINTZEL, PE ;
KENNEDY, PE .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (02) :283-285
[6]   TEMPERATURE EFFECTS ON THE AGGREGATION STATE AND ACTIVITY OF AMPHOTERICIN-B [J].
LAMBING, HE ;
WOLF, BD ;
HARTSEL, SC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1152 (01) :185-188
[7]   POLYDISPERSITY OF AGGREGATES FORMED BY THE POLYENE ANTIBIOTIC AMPHOTERICIN-B AND DEOXYCHOLATE - A SPIN LABEL STUDY [J].
LAMYFREUND, MT ;
FERREIRA, VFN ;
SCHREIER, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (02) :207-212
[8]   CHARACTERIZATION AND TIME-DEPENDENCE OF AMPHOTERICIN-B - DEOXYCHOLATE AGGREGATION BY QUASI-ELASTIC LIGHT-SCATTERING [J].
LAMYFREUND, MT ;
SCHREIER, S ;
PEITZSCH, RM ;
REED, WF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (03) :262-266
[9]   Quality evaluation by capillary electrophoresis of amphotericin B injection after filtration through various membrane filters [J].
Makino, K ;
Hirakawa, M ;
Goto, Y ;
Nakashima, K ;
Kataoka, Y ;
Oishi, R .
ELECTROPHORESIS, 1998, 19 (16-17) :2930-2934
[10]   ANTI-FUNGAL AGENTS USEFUL IN THERAPY OF SYSTEMIC FUNGAL-INFECTIONS [J].
MEDOFF, G ;
BRAJTBURG, J ;
KOBAYASHI, GS ;
BOLARD, J .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 :303-330